IPQ Analytics

IPQ Analytics builds computational models of disease that reflect real-world complexities from clinic to molecular processes. Their proprietary Symphony platform leverages AI, machine learning, big data, and knowledge graphs to optimize target selection and improve clinical trial outcomes. The company provides service-based solutions throughout the drug development lifecycle but does not appear to have its own therapeutic pipeline in human trials yet. The company's main service is the development of new treatments for complex and hard-to-treat diseases using its proprietary Symphony platform, which includes a suite of innovative solutions designed to optimize target selection and improve clinical trial success.